Cogent Biosciences, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Cogent Biosciences, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $45.71M, a 88.50% increase year-over-year.
- Cogent Biosciences, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $215.75M.
- Cogent Biosciences, Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $24.25M.
- Cogent Biosciences, Inc. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $161.79M, a 0.08% decline year-over-year.
- Cogent Biosciences, Inc. stock issued during period, value, new issues for fiscal 2020 was $107.73M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $45.71M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $215.75M 10-Q · filed 2025-11-07 | |
| 2025-03-31 | $24.25M 10-Q · filed 2026-08-10 | |
| 2023-06-30 | $161.79M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $161.91M 10-Q · filed 2023-11-07 | |
| 2020-12-31 | $107.73M 10-K · filed 2021-03-16 | |
| 2020-03-31 | $262.00K 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |